|
Post by edvarney on Sept 30, 2017 15:32:57 GMT -5
This is a truly good find!! Saunders book on Nursing current up to date 2017-18 yet... If Afrezza is acknowledged for immediate on-set over all other fast acting insulins and specifically 25 minutes faster than all others; My first question becomes, doesn't that qualify Afrezza as a in a class of its OWN?? For onset..alone.. I am truly amazed that Afrezza is this far along in the system of the Medical Community who are delivering to the patient!! The latest knowledge in new Insulins is being taught where it all starts!!! I say this Train is on track and picking up speed every day!!! Kudo's to Mike C. for all his personal effort to get Afrezza over the hump!!
We shall know more details on this is hours!!!
|
|
|
PDUFA
Sept 30, 2017 16:03:05 GMT -5
Post by dreamboatcruise on Sept 30, 2017 16:03:05 GMT -5
This is a truly good find!! Saunders book on Nursing current up to date 2017-18 yet... If Afrezza is acknowledged for immediate on-set over all other fast acting insulins and specifically 25 minutes faster than all others; My first question becomes, doesn't that qualify Afrezza as a in a class of its OWN?? For onset..alone.. I am truly amazed that Afrezza is this far along in the system of the Medical Community who are delivering to the patient!! The latest knowledge in new Insulins is being taught where it all starts!!! I say this Train is on track and picking up speed every day!!! Kudo's to Mike C. for all his personal effort to get Afrezza over the hump!! We shall know more details on this is hours!!! It's inhaled, it has a very unique pk/pd profile... sure, one could say it's in a class of its own. Only question is whether that distinction is recognized as meaningful... by FDA for label, by insurers, by ADA, by doctors, etc. If FDA were to allow a new designation of "ultra rapid", that might make it easier to drive change with the others (though perhaps not guaranteed). It will still likely be a long row to hoe before we see all the change we'd like to see... such as ADA treatment guidelines acknowledging unique clinical usefulness of an insulin with quick enough onset to serve as first phase insulin trigger (probably years away from that).
|
|
|
PDUFA
Oct 1, 2017 16:04:40 GMT -5
Post by kimi on Oct 1, 2017 16:04:40 GMT -5
Really great find -
There's no reason to build new "rapid classes" like ultra rapid.
nothing is faster than "immediate"!
The new keydifferentiation.
|
|